References
Tam LS, Li EK, Shang Q et al (2011) Tumor necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study. Ann Rheum Dis 70:705–706
Di Minno MND, Iervolino S, Peluso R et al (2011) Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α (TNF-α)-blockers and traditional disease modifying anti-rheumatic drugs. Arterioscler Thromb Vasc Biol 31:705–712
Benagiano M, Azzurri A, Ciervo A et al (2003) T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 100:6658–6663
Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467
Coates LC, Cook R, Leeka KA et al (2010) Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res 62:970–976
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Minno, M.N.D., Iervolino, S., Peluso, R. et al. TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis. Intern Emerg Med 7 (Suppl 2), 97–98 (2012). https://doi.org/10.1007/s11739-011-0704-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0704-6